Cargando…
Reduced eIF4E function impairs B-cell leukemia without altering normal B-lymphocyte function
The cap-binding protein eukaryotic initiation factor 4E (eIF4E) promotes translation of mRNAs associated with proliferation and survival and is an attractive target for cancer therapeutics. Here, we used Eif4e germline and conditional knockout models to assess the impact of reduced Eif4e gene dosage...
Autores principales: | Chiu, Honyin, Buono, Roberta, Jackson, Leandra V., Herzog, Lee-or, Mallya, Sharmila, Conn, Crystal S., Ruggero, Davide, Fruman, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261676/ https://www.ncbi.nlm.nih.gov/pubmed/34278258 http://dx.doi.org/10.1016/j.isci.2021.102748 |
Ejemplares similares
-
Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax
por: Herzog, Lee-or, et al.
Publicado: (2020) -
Targeting eIF4F translation complex sensitizes B-ALL cells to tyrosine kinase inhibition
por: Vo, Thanh-Trang, et al.
Publicado: (2021) -
The Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and Differentiation
por: Chiu, Honyin, et al.
Publicado: (2017) -
Synergistic activation of eIF4A by eIF4B and eIF4G
por: Nielsen, Klaus H., et al.
Publicado: (2011) -
eIF2A, an initiator tRNA carrier refractory to eIF2α kinases, functions synergistically with eIF5B
por: Kim, Eunah, et al.
Publicado: (2018)